Evidence map›Paper›PMID 33679644›Full record

ArticleFrontiers in microbiology2021

Establishment and Application of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for Detection of

Keyi Yu, Zhenzhou Huang, Ying Li, Qingbo Fu, Lirong Lin, Shiyao Wu, Hang Dai, Hongyan Cai, Yue Xiao, Ruiting Lan and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Emergence ofOne health (Amsterdam, Netherlands) · 2025
    Article
  4. Polyphasic discrimination ofApplied and environmental microbiology · 2025
    Article
  5. Article
  6. Review
  7. First case report ofFrontiers in medicine · 2025
    Article
  8. Review
  9. Investigation of Carriers ofAnimals : an open access journal from MDPI · 2024
    Article
  10. Article
  11. Characterization of CRISPR-Cas Systems inPathogens (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Virulence · 2022
    Review
  16. Frontiers in cellular and infection microbiology · 2022
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Keyi YuNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), State Key Laboratory for Infectious Disease Prevention and Control, Beijing, China.
Zhenzhou HuangNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), State Key Laboratory for Infectious Disease Prevention and Control, Beijing, China.
Ying LiWorkstation for Microbial Infectious Disease, Shunyi District Center for Disease Control and Prevention, Beijing, China.
Qingbo FuZybio Inc., Chongqing, China.
Lirong LinZybio Inc., Chongqing, China.
Shiyao WuZybio Inc., Chongqing, China.
Hang DaiNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), State Key Laboratory for Infectious Disease Prevention and Control, Beijing, China.
Hongyan CaiNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), State Key Laboratory for Infectious Disease Prevention and Control, Beijing, China.
Yue XiaoNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), State Key Laboratory for Infectious Disease Prevention and Control, Beijing, China.
Ruiting LanSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.
Duochun WangNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), State Key Laboratory for Infectious Disease Prevention and Control, Beijing, China.
State Key Laboratory of Infectious Disease Prevention and ControlChinese Center For Disease Control and Prevention · CNNational Institute for Communicable Disease Control and Prevention · CNUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

detectionestablishment and applicationMALDI-TOF mass spectrometrymultilocus sequence analysisShewanella

Identifiers

PMID33679644
PMCPMC7930330
OpenAlexW3131441487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.